<DOC>
	<DOCNO>NCT00048152</DOCNO>
	<brief_summary>This study compare kidney function kidney transplant patient follow treatment various combination Zenapax , CellCept , corticosteroid , Neoral ( Cyclosporine ) . The anticipated time study treatment 6-12 month , target sample size 500+ individual .</brief_summary>
	<brief_title>A Study Assess Use Zenapax ( Daclizumab ) CellCept ( Mycophenolate Mofetil ) Improve Kidney Function Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Daclizumab</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>adult patient great 18 year age recipients primary kidney transplant singleorgan recipient ( kidney ) previous treatment Zenapax history malignancy ( except localize skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>